Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Gemfields celebrates Zambia's suspension of hefty emerald export duty

(Sharecast News) - Gemstone miner Gemfields has hailed the lifting of a 15% export duty that applied to emeralds from Zambia, the world's largest emerald exporter. The Zambian government originally revoked the 2019 suspension of a 15% export duty on precious gemstones on 1 January, directly impacting the stones mined by Kagem Mining, which is 75%-owned by Gemfields and 25%-owned by the government's Industrial Development Corporation.

The levy applied on top of the existing 6% mineral royalty tax and meant that Kagem faced an effective tax on revenues of 21% (in addition to corporation tax of 30%).

That compares with taxes on revenues of just 2% and 2.5% in Brazil and Colombia, respectively - the world's next largest emerald exporters after Zambia.

Gemfields, which said it was given no notice of the New Years Day decision, has seen its share price tumble 17% since the start of 2025 to 5.75p as of Tuesday's close.

However, shares were 1% higher on Wednesday after Zambia's finance minister suspended the controversial duty effective immediately.

"We express our sincere thanks to President Hakainde Hichilema's government for their prompt and impressive action in addressing the 15% export duty on precious gemstones," said Gemfields' chief executive Sean Gilbertson.

"The Zambian emerald sector has delivered phenomenal growth over the last 16 years and is today - by a significant margin -the world's largest emerald exporter. The government's collaborative approach and decisive action are clear demonstrations of its intent to deliver growth and jobs for Zambia and this step puts our industry back on track to continue that trajectory."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.